<!DOCTYPE html>
<html lang="en">
<head>

  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>MSK Synoptic MCQs</title>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&display=swap" rel="stylesheet">
  <style>
    :root {
      --primary-color: #c83232;
      --primary-light: #3182ce;
      --accent-color: #edf2f7;
      --correct-bg: #e6fffa;
      --correct-text: #276749;
      --incorrect-bg: #fff5f5;
      --incorrect-text: #c53030;
      --border-radius: 12px;
      --transition-speed: 0.3s;
    }

    * {
      box-sizing: border-box;
    }

    body {
      font-family: 'Inter', sans-serif;
      background-color: #f9fafb;
      color: #1a202c;
      margin: 0;
      padding: 40px 20px;
      display: flex;
      flex-direction: column;
      align-items: center;
    }

    h1 {
      font-size: 2rem;
      margin-bottom: 30px;
      color: var(--primary-color);
    }

    .question-box {
      background-color: #ffffff;
      width: 100%;
      max-width: 700px;
      padding: 30px;
      border-radius: var(--border-radius);
      box-shadow: 0 10px 30px rgba(0, 0, 0, 0.06);
      transition: all var(--transition-speed) ease-in-out;
    }

    h2 {
      font-size: 1.3rem;
      margin-bottom: 20px;
    }

    .options button {
      background-color: var(--accent-color);
      border: 2px solid transparent;
      border-radius: var(--border-radius);
      padding: 15px;
      font-size: 1rem;
      margin-bottom: 12px;
      width: 100%;
      text-align: left;
      transition: all var(--transition-speed) ease;
      cursor: pointer;
    }

    .options button:hover {
      background-color: var(--primary-light);
      color: white;
    }

    .feedback {
      padding: 15px;
      margin-top: 20px;
      border-radius: var(--border-radius);
      font-size: 1rem;
      font-weight: 600;
      display: none;
    }

    .feedback.correct {
      background-color: var(--correct-bg);
      color: var(--correct-text);
    }

    .feedback.incorrect {
      background-color: var(--incorrect-bg);
      color: var(--incorrect-text);
    }

    .explanations {
      margin-top: 10px;
      font-size: 1rem;
      color: #4a5568;
    }

    .nav-buttons {
      display: flex;
      justify-content: space-between;
      margin-top: 30px;
      max-width: 700px;
      width: 100%;
    }

    .nav-buttons button {
      background-color: var(--primary-color);
      color: white;
	  margin: 0 10px;
      border: none;
      padding: 12px 20px;
      font-size: 1rem;
      border-radius: var(--border-radius);
      cursor: pointer;
      transition: background-color var(--transition-speed) ease;
    }

    .nav-buttons button:hover {
      background-color: #1a365d;
    }

    @media (max-width: 600px) {
      .nav-buttons {
        flex-direction: column;
        gap: 10px;
      }
    }
	
	.score-box-container {
	  width: 100%;
	  max-width: 700px;
	  height: 20px;
	  background-color: #e2e8f0;
	  border-radius: 10px;
	  margin-top: 20px;
	  overflow: hidden;
	  position: relative;
	}
	
	.score-box-fill {
	  height: 100%;
	  width: 0%;
	  background-color: #38a169; /* Default: green for high score */
	  border-radius: 10px;
	  transition: width 0.4s ease;
	  display: flex;
	  align-items: center;
	  justify-content: center;
	}
	
	.score-box-label {
	  color: white;
	  font-weight: bold;
	  font-size: 0.9rem;
	  z-index: 1;
	}
	
	.score-box.correct {
	  background-color: #e6fffa;
	  border-color: #38b2ac;
	  color: #276749;
	}
	
	.score-box.warning {
	  background-color: #fefcbf;
	  border-color: #ecc94b;
	  color: #975a16;
	}
	
	.score-box.low {
	  background-color: #fff5f5;
	  border-color: #fc8181;
	  color: #c53030;
	}
	#review-controls {
	  justify-content: center;
	  margin-top: 10px;
	}
	
	#review-controls button {
	  background-color: #ed8936;
	  border: none;
	  padding: 10px 16px;
	  font-size: 0.95rem;
	  border-radius: var(--border-radius);
	  cursor: pointer;
	  transition: background-color 0.3s ease;
	}
	
	#review-controls button:hover {
	  background-color: #dd6b20;
	}
	#return-controls {
	  margin-top: 20px;
	  justify-content: center;
	}
	
	#return-controls button {
	  background-color: #718096;
	  color: white;
	  border: none;
	  padding: 10px 20px;
	  font-size: 1rem;
	  border-radius: 8px;
	  cursor: pointer;
	  transition: background-color 0.2s ease;
	}
	
	#return-controls button:hover {
	  background-color: #4a5568;
	}
	
	.reset-button {
	  margin-top: 30px;
	  background-color: #e53e3e;
	  color: #fff;
	  padding: 12px 20px;
	  border: none;
	  border-radius: 10px;
	  font-size: 1rem;
	  font-weight: 600;
	  cursor: pointer;
	  transition: background-color 0.3s ease, transform 0.2s ease;
	  box-shadow: 0 4px 10px rgba(0, 0, 0, 0.08);
	}
	
	.centered {
	  display: flex;
	  justify-content: center;
	  margin-top: 30px;
	}
	
	.reset-button:hover {
	  background-color: #c53030;
	  transform: scale(1.02);
	}
	
	.reset-button:active {
	  transform: scale(0.98);
	}
	
	
    #educational-section {
	  max-width: 880px;
	  margin: 60px auto;
	  padding: 40px;
	  background: var(--background);
	  border-radius: var(--radius);
	}
	
	
	.summary-item {
	  background: var(--card-bg);
	  backdrop-filter: blur(12px);
	  border: 1px solid var(--glass-border);
	  border-radius: var(--radius);
	  box-shadow: 0 12px 32px rgba(0, 0, 0, 0.05);
	  margin-bottom: 20px;
	  overflow: hidden;
	  transition: box-shadow var(--transition);
	}
	
	.summary-item:hover {
	  box-shadow: 0 16px 40px rgba(0, 0, 0, 0.08);
	}
	
	.summary-toggle {
	  background: none;
	  border: none;
	  padding: 20px 24px;
	  width: 100%;
	  text-align: left;
	  font-size: 1.1rem;
	  font-weight: 600;
	  color: var(--text-main);
	  display: flex;
	  justify-content: space-between;
	  align-items: center;
	  cursor: pointer;
	  transition: background var(--transition);
	}
	
	.summary-toggle:hover {
	  background: rgba(99, 102, 241, 0.1);
	}
	
	.summary-toggle::after {
	  content: "›";
	  font-size: 1.2rem;
	  transform: rotate(0deg);
	  transition: transform 0.3s ease;
	}
	
	.summary-toggle.active::after {
	  transform: rotate(90deg);
	}
	
	.summary-content {
	  display: none;
	  padding: 20px 24px;
	  color: var(--text-muted);
	  font-size: 0.95rem;
	  line-height: 1.6;
	  animation: fadeIn 0.4s ease forwards;
	}
	
	@keyframes fadeIn {
	  from { opacity: 0; transform: translateY(-10px); }
	  to { opacity: 1; transform: translateY(0); }
	}
	
	.summary-content ul,
	.summary-content ol {
	  margin-left: 1.5rem;
	}
	
	.summary-content li {
	  margin-bottom: 8px;
	}
	
	#auth-section {
	  background: white;
	  padding: 40px 30px;
	  border-radius: 12px;
	  box-shadow: 0 12px 40px rgba(0, 0, 0, 0.1);
	  width: 100%;
	  max-width: 400px;
	  text-align: center;
	  animation: fadeIn 0.5s ease forwards;
	}
	
	#auth-section h2 {
	  margin-bottom: 20px;
	  font-size: 1.5rem;
	  color: #2b6cb0;
	}
	
	/* Input fields */
	#auth-section input {
	  width: 100%;
	  padding: 12px 16px;
	  margin-bottom: 14px;
	  border: 1px solid #cbd5e0;
	  border-radius: 8px;
	  font-size: 1rem;
	  transition: border-color 0.2s ease;
	}
	
	#auth-section input:focus {
	  border-color: #3182ce;
	  outline: none;
	}
	
	/* Buttons */
	#auth-section button {
	  width: 48%;
	  padding: 12px 16px;
	  margin-top: 10px;
	  font-size: 1rem;
	  font-weight: 600;
	  color: white;
	  border: none;
	  border-radius: 8px;
	  cursor: pointer;
	  transition: transform 0.2s ease, background-color 0.3s ease;
	}
	
	#auth-section button:hover {
	  transform: translateY(-2px);
	}
	
	#auth-section button:active {
	  transform: scale(0.98);
	}
	
	#auth-section button:first-of-type {
	  background-color: #2b6cb0;
	}
	
	#auth-section button:first-of-type:hover {
	  background-color: #2c5282;
	}
	
	#auth-section button:last-of-type {
	  background-color: #38a169;
	}
	
	#auth-section button:last-of-type:hover {
	  background-color: #2f855a;
	}
	
	/* Logout button */
	#logout-btn {
	  background-color: #e53e3e;
	  margin-top: 20px;
	  width: 100%;
	}
	
	#logout-btn:hover {
	  background-color: #c53030;
	}
	
	/* Status text */
	#auth-status {
	  color: #2b6cb0;
	  margin-top: 15px;
	  font-weight: 500;
	}
	
	/* Fade animation */
	@keyframes fadeIn {
	  from {
	    opacity: 0;
	    transform: translateY(15px);
	  }
	  to {
	    opacity: 1;
	    transform: translateY(0);
	  }
	}
  </style>
</head>
<body>
	<div id="auth-section" style="max-width: 400px; margin: 60px auto; text-align: center;">
    <h2>Welcome!</h2>
    <input id="username-input" type="text" placeholder="Enter your name" style="padding: 12px; width: 100%; margin-bottom: 15px;" />
    <button onclick="loginUser()" style="padding: 10px 20px;">Start Practice</button>
    <div id="auth-status" style="margin-top: 20px; font-weight: bold;"></div>
  </div>
<div id="app-container" style="display: none;">
  <h1>MSK Synoptic MCQ Practice</h1>
<div id="user-stats" style="margin-top: 20px; text-align: center; display: none;">
  <h3>Your Progress</h3>
  <p id="stats-summary">Loading...</p>
</div>
  <div class="nav-buttons" style="justify-content: center;">
    <button onclick="switchTab('quiz')">Practice MCQs</button>
    <button onclick="switchTab('education')">Educational Summaries</button>
    <button onclick="switchTab('conditions')">Conditions</button>
  </div>

  <!-- Quiz Section -->
  <div id="quiz-section">

    <div style="max-width: 700px; width: 100%; margin: 30px auto 20px;">
      <div style="margin-bottom: 10px;">
        <label for="question-select">Jump to question:</label>
        <select id="question-select" onchange="goToQuestion(this.value)">
        </select>
      </div>
      <div style="height: 10px; background: #e2e8f0; border-radius: 5px;">
        <div id="progress-bar" style="height: 10px; width: 0%; background: var(--primary-color); border-radius: 5px;"></div>
      </div>
    </div>

    <div class="question-box">
      <h2 id="question-text">Loading question...</h2>
      <div class="options" id="options-container"></div>
      <div class="feedback" id="feedback-box"></div>
    </div>

    <div class="nav-buttons">
      <button onclick="prevQuestion()">⟵ Previous</button>
      <button onclick="nextQuestion()">Next ⟶</button>
    </div>

    <div class="nav-buttons" id="review-controls">
      <button onclick="startReview('incorrect')">Redo Incorrect Questions</button>
      <button onclick="startReview('correct')">Redo Correct Questions</button>
    </div>

    <div class="nav-buttons" id="return-controls" style="display: none;">
      <button onclick="exitReview()">Back to Practice</button>
    </div>
	<div class="centered">
    <button class="reset-button" onclick="resetProgress()">Reset All Progress</button>
	</div>
	
  </div>

  <!-- Educational Section -->
  <!-- Educational Summary Section -->
<section id="educational-section" style="max-width: 700px; width: 100%; margin-top: 40px;">
  <h2 style="color: var(--primary-color); margin-bottom: 20px;">Educational Summaries</h2>
  
  
<div class="summary-grid">
  <div class="summary-item">
  <button class="summary-toggle">1. Homeostasis & Control Systems</button>
  <div class="summary-content">
    <ul>
      <li><strong>Definition:</strong> Homeostasis is the body’s ability to maintain a stable internal environment despite external changes.</li>
      <li><strong>Example:</strong> Regulation of body temperature via sweating and shivering.</li>
      <li><strong>Core components:</strong>
        <ul>
          <li>Receptors detect deviation from set points.</li>
          <li>Control centres (e.g. hypothalamus) process the signal.</li>
          <li>Effectors restore balance (e.g. sweat glands, muscles).</li>
        </ul>
      </li>
      <li><strong>Mechanism:</strong> Mostly governed by negative feedback loops.</li>
      <li><strong>Failure of homeostasis:</strong> Underlies diseases like diabetes, fever, and hypertension.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">2. Thermoregulation & Autonomic Nervous System</button>
  <div class="summary-content">
    <ul>
      <li><strong>Function:</strong> Maintains core body temperature (36.3–37.3°C).</li>
      <li><strong>Skin blood flow regulation:</strong>
        <ul>
          <li>Glabrous skin: passive control via vasoconstriction.</li>
          <li>Non-glabrous skin: active vasodilation via sympathetic cholinergic nerves.</li>
        </ul>
      </li>
      <li><strong>Raynaud’s Phenomenon:</strong>
        <ul>
          <li>Primary: exaggerated vasoconstriction to cold.</li>
          <li>Secondary: linked with autoimmune diseases.</li>
        </ul>
      </li>
      <li><strong>Clinical tool:</strong> Sympathetic release test to assess thermoregulatory function.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">3. Histopathology of Inflammation</button>
  <div class="summary-content">
    <ul>
      <li><strong>Acute inflammation:</strong> Neutrophil infiltration, vascular leakiness, cytokine surge.</li>
      <li><strong>Chronic inflammation:</strong> Lymphocytes and plasma cells; common in autoimmune disease (e.g. RA).</li>
      <li><strong>Granulomas:</strong> Collections of macrophages, often in TB or sarcoidosis.</li>
      <li><strong>Key pathology terms:</strong>
        <ul>
          <li>Abscess: pus-filled cavity.</li>
          <li>Empyema: pus in body cavity.</li>
          <li>Ulcer: full-thickness epithelial loss with necrosis.</li>
          <li>Sinus tract: blind-ended inflammatory tunnel.</li>
        </ul>
      </li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">4. Overview of Joints</button>
  <div class="summary-content">
    <ul>
      <li><strong>Structural types:</strong>
        <ul>
          <li>Fibrous: e.g. sutures, gomphosis.</li>
          <li>Cartilaginous: synchondroses, symphyses.</li>
          <li>Synovial: have cavity, membrane, capsule, e.g. knee joint.</li>
        </ul>
      </li>
      <li><strong>Synovial Joint Types:</strong> Hinge (elbow), Pivot (radioulnar), Ball & socket (hip), Saddle (thumb).</li>
      <li><strong>Functional types:</strong>
        <ul>
          <li>Synarthrosis: no movement.</li>
          <li>Amphiarthrosis: limited.</li>
          <li>Diarthrosis: free movement.</li>
        </ul>
      </li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">5. Granulomatous Diseases</button>
  <div class="summary-content">
    <ul>
      <li><strong>Definition:</strong> Chronic inflammation with granulomas—organized macrophage clusters.</li>
      <li><strong>Classic causes:</strong> Tuberculosis (caseating), Sarcoidosis (non-caseating).</li>
      <li><strong>Histology:</strong> Giant cells, central necrosis (caseous in TB), Ziehl-Neelsen stain + in TB.</li>
      <li><strong>Clinical case relevance:</strong> Granulomas in sarcoidosis are non-caseating and ZN stain negative.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">6. Sympathetic Nervous System in Thermoregulation</button>
  <div class="summary-content">
    <ul>
      <li><strong>Key Concept:</strong> Skin blood flow is critical for temperature control.</li>
      <li><strong>Cutaneous vessels:</strong>
        <ul>
          <li>Controlled by sympathetic vasoconstrictors (tonic).</li>
          <li>Glabrous (palms, soles) vs. non-glabrous (arms, back).</li>
        </ul>
      </li>
      <li><strong>Test:</strong> Sympathetic release test checks vasodilation via temperature plateau.</li>
      <li><strong>Disorders:</strong> Raynaud’s, peripheral artery disease (gangrene risk).</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">7. Disease as Failure of Homeostasis</button>
  <div class="summary-content">
    <ul>
      <li><strong>Definition:</strong> When regulatory systems can’t maintain stability.</li>
      <li><strong>Examples:</strong>
        <ul>
          <li>Cardiovascular: chronic hypertension, heart failure.</li>
          <li>Endocrine: diabetes mellitus (insulin deficiency).</li>
        </ul>
      </li>
      <li><strong>Mechanism:</strong> Positive feedback loops take over, e.g. fever.</li>
      <li><strong>Clinical implication:</strong> Maintaining homeostasis is vital in all physiological systems.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">8. Types of Necrosis</button>
  <div class="summary-content">
    <ul>
      <li><strong>Coagulative:</strong> Seen in MI. Preserved architecture, pink eosinophilic cytoplasm.</li>
      <li><strong>Liquefactive:</strong> Brain injury. Complete tissue digestion.</li>
      <li><strong>Caseous:</strong> TB. Cheese-like appearance, seen in granulomas.</li>
      <li><strong>Fat:</strong> Enzymatic destruction of adipose tissue, seen in pancreatitis.</li>
      <li><strong>Fibrinoid:</strong> Vessel wall necrosis, seen in vasculitis.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">9. Synovial Joint Anatomy</button>
  <div class="summary-content">
    <ul>
      <li><strong>Key components:</strong>
        <ul>
          <li>Articular cartilage: hyaline, cushions joint ends.</li>
          <li>Synovial membrane: secretes fluid.</li>
          <li>Joint cavity: contains synovial fluid.</li>
          <li>Capsule & ligaments: provide support.</li>
        </ul>
      </li>
      <li><strong>Function:</strong> Freely moveable (diarthrotic); supported by tendons, muscles, bursae.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">10. Homeostatic Control System</button>
  <div class="summary-content">
    <ul>
      <li><strong>3 parts:</strong>
        <ol>
          <li>Sensor: detects change (e.g. thermal receptors).</li>
          <li>Control Centre: brain/hypothalamus.</li>
          <li>Effector: restores equilibrium (e.g. sweat glands, muscles).</li>
        </ol>
      </li>
      <li><strong>Feedback types:</strong>
        <ul>
          <li>Negative: stabilizing (e.g. BP regulation).</li>
          <li>Positive: amplifying (e.g. clotting, fever).</li>
        </ul>
      </li>
      <li><strong>Quiz:</strong> What returns elevated body temp to normal? <em>Answer: Sweating.</em></li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">11. Blood-Brain Barrier & Glial Cells</button>
  <div class="summary-content">
    <p><strong>Astrocytes:</strong> Maintain BBB integrity, regulate ionic environment, support neurons.</p>
    <p><strong>Microglia:</strong> CNS macrophages, key in immune surveillance and phagocytosis.</p>
    <p><strong>Oligodendrocytes:</strong> Myelinate multiple CNS axons.</p>
    <p><strong>Ependymal Cells:</strong> Line ventricles, produce & circulate CSF.</p>
    <p><strong>Clinical Relevance:</strong> BBB breakdown occurs in MS, infections, trauma.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">12. Myelin & Conduction</button>
  <div class="summary-content">
    <p><strong>Schwann cells:</strong> Myelinate single PNS axons; promote regeneration.</p>
    <p><strong>Oligodendrocytes:</strong> CNS equivalent; no regeneration.</p>
    <p><strong>Saltatory Conduction:</strong> APs jump between nodes of Ranvier — increases speed.</p>
    <p><strong>Diseases:</strong> Demyelination in MS (CNS) and Guillain-Barré (PNS).</p>
    <p><strong>Slide Tip:</strong> Myelinated axons = fast, white matter; unmyelinated = slow, grey matter.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">13. Autonomic Nervous System (ANS)</button>
  <div class="summary-content">
    <p><strong>Sympathetic:</strong> "Fight or flight" — ↑ HR, bronchodilation, pupil dilation.</p>
    <p><strong>Parasympathetic:</strong> "Rest and digest" — ↓ HR, ↑ GI motility.</p>
    <p><strong>Neurotransmitters:</strong><br>Sympathetic: ACh (pre), Noradrenaline (post).<br>Parasympathetic: ACh both pre- and post-ganglionic.</p>
    <p><strong>Clinical Cases:</strong> Beta-blockers inhibit sympathetic HR response.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">14. Skin Barrier & Stratification</button>
  <div class="summary-content">
    <p><strong>Layers (deep to superficial):</strong> Basale, Spinosum, Granulosum, Lucidum (palms/soles), Corneum.</p>
    <p><strong>Keratinocytes:</strong> Major cell; produce keratin for waterproofing.</p>
    <p><strong>Melanocytes:</strong> Pigment production, located in basal layer.</p>
    <p><strong>Clinical Example:</strong> Psoriasis = hyperproliferation of keratinocytes, ↑ stratum corneum.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">15. Ion Transport Across Membranes</button>
  <div class="summary-content">
    <p><strong>Na⁺/K⁺ ATPase:</strong> 3 Na⁺ out, 2 K⁺ in — maintains resting potential.</p>
    <p><strong>Calcium Channels:</strong> Involved in muscle contraction, NT release.</p>
    <p><strong>Passive vs Active Transport:</strong><br>Passive: Diffusion, facilitated (e.g. GLUT).<br>Active: Uses ATP (e.g. Na⁺/K⁺ pump).</p>
    <p><strong>Osmosis:</strong> Water moves toward hypertonic solution.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">16. Frameshift Mutations</button>
  <div class="summary-content">
    <p><strong>Definition:</strong> Insertion/deletion not divisible by 3 → shifts reading frame.</p>
    <p><strong>Consequence:</strong> Alters entire downstream amino acid sequence.</p>
    <p><strong>Example:</strong> In CFTR gene → cystic fibrosis.</p>
    <p><strong>Compare:</strong><br>Missense: 1 base → different aa.<br>Nonsense: Premature stop codon.<br>Silent: No aa change.</p>
    <p><strong>Slide Detail:</strong> tRNA reads mRNA in 3-base codons.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">17. Ethical Principles in Medicine</button>
  <div class="summary-content">
    <p><strong>Autonomy:</strong> Respect patient choice — even refusal of treatment.</p>
    <p><strong>Beneficence:</strong> Act in patient’s best interest.</p>
    <p><strong>Non-maleficence:</strong> “Do no harm.”</p>
    <p><strong>Justice:</strong> Fair access to healthcare.</p>
    <p><strong>Clinical Dilemma:</strong> Jehovah's Witness refusing transfusion — autonomy respected.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">18. Macromolecules & Their Roles</button>
  <div class="summary-content">
    <p><strong>Carbohydrates:</strong> Energy — glucose, glycogen (liver & muscle).</p>
    <p><strong>Proteins:</strong> Structure (collagen), transport (Hb), enzymes.</p>
    <p><strong>Lipids:</strong> Long-term energy (triglycerides), membranes (phospholipids).</p>
    <p><strong>Nucleic Acids:</strong> DNA (genetic storage), RNA (expression).</p>
    <p><strong>Lecture Highlight:</strong> ATP is <em>not</em> a storage molecule, but an energy currency.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">19. Cell Death: Apoptosis vs Necrosis</button>
  <div class="summary-content">
    <p><strong>Apoptosis:</strong><br>Programmed, energy-dependent.<br>Cell shrinkage, chromatin condensation, apoptotic bodies.<br>No inflammation.</p>
    <p><strong>Necrosis:</strong><br>Unregulated cell death (e.g. hypoxia).<br>Cell swelling, rupture, inflammation.</p>
    <p><strong>Clinical Insight:</strong> Chemotherapy often induces apoptosis in cancer cells.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">20. Central Nervous System Divisions</button>
  <div class="summary-content">
    <p><strong>Cerebrum:</strong> Sensory processing, voluntary movement, higher cognition.</p>
    <p><strong>Cerebellum:</strong> Balance, coordination.</p>
    <p><strong>Brainstem:</strong> Autonomic control (breathing, HR); midbrain, pons, medulla.</p>
    <p><strong>Spinal Cord:</strong> Reflex arcs, ascending (sensory) & descending (motor) tracts.</p>
    <p><strong>Case Link:</strong> Stroke in cerebellum → ataxia; brainstem stroke → life-threatening.</p>
  </div>
</div>
<!-- Educational Summaries 31–40 -->
<div class="summary-item">
  <button class="summary-toggle">21. Reflex Arcs</button>
  <div class="summary-content">
    <p><strong>Components:</strong> Sensory receptor → Afferent neuron → Integration center → Efferent neuron → Effector.</p>
    <p><strong>Example:</strong> Patellar reflex (monosynaptic).</p>
    <p><strong>Clinical note:</strong> Hyperreflexia = UMN lesion; Hyporeflexia = LMN or peripheral neuropathy.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">22. Autonomic Receptors</button>
  <div class="summary-content">
    <p><strong>Sympathetic (Adrenergic):</strong></p>
    <ul>
      <li>α₁: Vasoconstriction (↑BP)</li>
      <li>β₁: ↑HR, ↑contractility</li>
      <li>β₂: Bronchodilation, vasodilation in muscle</li>
    </ul>
    <p><strong>Parasympathetic (Cholinergic):</strong></p>
    <ul>
      <li>M₂: ↓HR</li>
      <li>M₃: Gland secretion, smooth muscle contraction (e.g. bladder)</li>
    </ul>
    <p><strong>Pharmacology tie-in:</strong> β-blockers block β₁; antimuscarinics block M₃.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">23. Sympathetic Chain & Outflow</button>
  <div class="summary-content">
    <p><strong>Thoracolumbar origin:</strong> T1–L2.</p>
    <p><strong>Preganglionic fibres:</strong> Short, release ACh.</p>
    <p><strong>Postganglionic fibres:</strong> Long, release NE (except sweat glands: ACh).</p>
    <p><strong>Chain ganglia:</strong> Allow signal to travel above/below initial spinal segment.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">24. Enteric Nervous System</button>
  <div class="summary-content">
    <p><strong>"Brain of the gut":</strong> Can function independently but modulated by ANS.</p>
    <p><strong>Plexuses:</strong></p>
    <ul>
      <li>Myenteric (Auerbach’s): Motility</li>
      <li>Submucosal (Meissner’s): Secretion, blood flow</li>
    </ul>
    <p><strong>Clinical relevance:</strong> Hirschsprung's = absence of ENS ganglia → megacolon.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">25. Blood Supply to CNS</button>
  <div class="summary-content">
    <p><strong>Brain:</strong></p>
    <ul>
      <li>Internal carotids → Anterior circulation</li>
      <li>Vertebral arteries → Posterior circulation</li>
      <li>Circle of Willis = anastomotic loop</li>
    </ul>
    <p><strong>Spinal cord:</strong></p>
    <ul>
      <li>Anterior spinal artery (motor)</li>
      <li>Posterior spinal arteries (sensory)</li>
    </ul>
    <p><strong>Clinical:</strong> Anterior spinal artery syndrome = bilateral motor loss.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">26. Cerebrospinal Fluid (CSF)</button>
  <div class="summary-content">
    <p><strong>Produced by:</strong> Choroid plexus (ependymal cells).</p>
    <p><strong>Flow:</strong> Lateral → 3rd → 4th ventricle → subarachnoid space.</p>
    <p><strong>Reabsorbed by:</strong> Arachnoid granulations into venous sinuses.</p>
    <p><strong>Clinical:</strong> Hydrocephalus = CSF accumulation due to obstruction or impaired drainage.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">27. Dural Layers and Meninges</button>
  <div class="summary-content">
    <p><strong>Dura mater:</strong> Tough outer layer.</p>
    <p><strong>Arachnoid mater:</strong> CSF flows beneath.</p>
    <p><strong>Pia mater:</strong> Directly covers brain/spinal cord.</p>
    <p><strong>Subarachnoid space:</strong> Site of lumbar puncture (L3–L4 in adults).</p>
    <p><strong>Clinical:</strong> Subarachnoid haemorrhage → "thunderclap" headache.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">28. Glutamate Excitotoxicity</button>
  <div class="summary-content">
    <p><strong>Glutamate:</strong> Major excitatory neurotransmitter.</p>
    <p><strong>Excess →</strong> Overactivation of NMDA/AMPA receptors → Ca²⁺ influx → Cell death.</p>
    <p><strong>Pathology:</strong> Seen in stroke, ALS, Alzheimer's.</p>
    <p><strong>Therapeutics:</strong> Riluzole reduces glutamate transmission (ALS).</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">29. Nerve Conduction Velocity</button>
  <div class="summary-content">
    <p><strong>Increased by:</strong> Myelination, larger axon diameter.</p>
    <p><strong>Decreased by:</strong> Demyelination (e.g. MS), compression injuries.</p>
    <p><strong>Clinical:</strong> Nerve conduction studies assess peripheral neuropathies.</p>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">30. Blood Supply to the Spinal Cord</button>
  <div class="summary-content">
    <p><strong>Anterior spinal artery:</strong> Supplies 2/3 of spinal cord (motor tracts).</p>
    <p><strong>Posterior spinal arteries:</strong> Supply dorsal columns (sensory).</p>
    <p><strong>Great radicular artery (of Adamkiewicz):</strong> Vital for thoracolumbar supply.</p>
    <p><strong>Infarct presentation:</strong> Paraparesis, loss of pain/temp, preserved proprioception.</p>
  </div>
</div>
<div class="summary-item">
  <button class="summary-toggle">31. Endocrine Pathophysiology</button>
  <div class="summary-content">
    <ul>
      <li><strong>Diabetes Mellitus:</strong>
        <ul>
          <li>Type 1: autoimmune destruction of beta cells, absolute insulin deficiency.</li>
          <li>Type 2: insulin resistance ± relative deficiency. Linked to obesity, lifestyle.</li>
        </ul>
      </li>
      <li><strong>Hormone axes:</strong> HPA (cortisol), HPT (thyroxine), HPG (sex hormones).</li>
      <li><strong>Adrenal disorders:</strong> Addison’s disease = primary adrenal insufficiency. Symptoms include fatigue, hyperpigmentation, low BP.</li>
      <li><strong>Endocrine feedback:</strong> Negative feedback predominant, e.g. cortisol suppressing ACTH.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">32. Immunology Basics</button>
  <div class="summary-content">
    <ul>
      <li><strong>Innate Immunity:</strong> First-line defense; includes neutrophils, macrophages, dendritic cells.</li>
      <li><strong>Adaptive Immunity:</strong> Specific; B-cells (humoral), T-cells (cell-mediated).</li>
      <li><strong>Antigen presentation:</strong> Via MHC I (all nucleated cells) to CD8+ T-cells, MHC II (APCs) to CD4+ T-cells.</li>
      <li><strong>Cytokines:</strong> Signaling molecules like IL-1, TNF-alpha, IFN-gamma.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">33. Haematology & Coagulation</button>
  <div class="summary-content">
    <ul>
      <li><strong>Anaemia types:</strong>
        <ul>
          <li>Microcytic: iron deficiency, thalassemia.</li>
          <li>Normocytic: blood loss, chronic disease.</li>
          <li>Macrocytic: B12/folate deficiency.</li>
        </ul>
      </li>
      <li><strong>Clotting Cascade:</strong> Intrinsic (aPTT), Extrinsic (PT), Common pathway leads to fibrin clot.</li>
      <li><strong>Platelet function:</strong> Adhesion (vWF), activation, aggregation (fibrinogen bridging via GPIIb/IIIa).</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">34. Pharmacology Principles</button>
  <div class="summary-content">
    <ul>
      <li><strong>Pharmacokinetics:</strong> ADME – Absorption, Distribution, Metabolism, Excretion.</li>
      <li><strong>Pharmacodynamics:</strong> Drug-receptor interactions, dose-response curves.</li>
      <li><strong>Tyrosine Kinase Inhibitors:</strong> e.g. Imatinib for CML, blocks BCR-ABL fusion protein.</li>
      <li><strong>Drug metabolism:</strong> Liver CYP450 enzymes – important for interactions.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">35. Cell Cycle & Cancer Mechanisms</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cell cycle checkpoints:</strong> G1/S (DNA damage), G2/M (replication), M (spindle).</li>
      <li><strong>Oncogenes:</strong> Gain of function → uncontrolled growth. e.g. RAS, HER2.</li>
      <li><strong>Tumour suppressors:</strong> Loss of function. e.g. p53, RB.</li>
      <li><strong>Apoptosis:</strong> Programmed cell death; p53 activates intrinsic mitochondrial pathway via Bax/Bak.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">36. Hypersensitivity Reactions</button>
  <div class="summary-content">
    <ul>
      <li><strong>Type I:</strong> Immediate, IgE-mediated. e.g. Anaphylaxis, hay fever.</li>
      <li><strong>Type II:</strong> Antibody-mediated cytotoxicity. e.g. Autoimmune haemolytic anaemia.</li>
      <li><strong>Type III:</strong> Immune complex deposition. e.g. SLE, post-strep glomerulonephritis.</li>
      <li><strong>Type IV:</strong> Delayed-type, T-cell mediated. e.g. TB skin test, contact dermatitis.</li>
    </ul>
  </div>
</div>
<div class="summary-item">
  <button class="summary-toggle">37. G Protein Signaling Types</button>
  <div class="summary-content">
    <ul>
      <li><strong>G protein-coupled receptors (GPCRs):</strong> 7-transmembrane receptors coupled to G proteins (alpha, beta, gamma subunits).</li>
      <li><strong>Gs (stimulatory):</strong> Activates adenylate cyclase → ↑ cAMP → activates PKA. Example: β-adrenergic receptors.</li>
      <li><strong>Gi (inhibitory):</strong> Inhibits adenylate cyclase → ↓ cAMP. Example: α2-adrenergic receptors, M2 receptors.</li>
      <li><strong>Gq:</strong> Activates phospholipase C → ↑ IP3/DAG → ↑ intracellular Ca²⁺ → activates PKC. Example: α1-adrenergic receptors, M1/M3 receptors.</li>
      <li><strong>Clinical:</strong> Cholera toxin locks Gs ON; Pertussis toxin locks Gi OFF.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">38. Collagen Types & Disorders</button>
  <div class="summary-content">
    <ul>
      <li><strong>Type I:</strong> Bone, skin, tendon – strongest. Defective in osteogenesis imperfecta.</li>
      <li><strong>Type II:</strong> Cartilage (hyaline), vitreous body, nucleus pulposus.</li>
      <li><strong>Type III:</strong> Reticulin – found in skin, vessels, uterus. Defective in vascular Ehlers-Danlos syndrome.</li>
      <li><strong>Type IV:</strong> Basement membranes. Affected in Alport syndrome & Goodpasture’s disease.</li>
      <li><strong>Type V:</strong> Found in cornea, placenta, and skin. Also involved in some types of EDS.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">39. Amino Acids – Types & Shorthand</button>
  <div class="summary-content">
    <ul>
      <li><strong>Essential AA:</strong> Cannot be synthesized – must be obtained from diet. e.g. Leucine, Lysine, Tryptophan.</li>
      <li><strong>Non-essential AA:</strong> Can be synthesized. e.g. Alanine, Glutamate.</li>
      <li><strong>Polar AA:</strong> Serine, Threonine, Asparagine, Glutamine.</li>
      <li><strong>Non-polar AA:</strong> Glycine, Alanine, Valine, Leucine, Isoleucine.</li>
      <li><strong>Aromatic:</strong> Phenylalanine (Phe, F), Tyrosine (Tyr, Y), Tryptophan (Trp, W).</li>
      <li><strong>Acidic:</strong> Aspartic acid (Asp, D), Glutamic acid (Glu, E).</li>
      <li><strong>Basic:</strong> Arginine (Arg, R), Lysine (Lys, K), Histidine (His, H).</li>
      <li><strong>Shorthand Tip:</strong> Know both 1-letter (e.g. F for Phe) and 3-letter codes (e.g. Phe).</li>
    </ul>
  </div>
</div>


</div>
</div>
</section>
<!-- Conditions Section -->
<section id="conditions-section" style="display: none; max-width: 900px; width: 100%; margin-top: 40px;">
  <h2 style="color: var(--primary-color); margin-bottom: 20px;">Clinical Conditions</h2>
  <div class="summary-grid">
    <!-- You can paste all your <div class="summary-item"> blocks for each condition here -->
    <!-- Example block: -->
    <div class="summary-item">
  <button class="summary-toggle">1. Homocystinuria</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Case+1+Overview+2024.pdf</li>
      <li><strong>Type:</strong> Autosomal recessive metabolic disorder.</li>
      <li><strong>Defect:</strong> Cystathionine beta-synthase (CBS) deficiency.</li>
      <li><strong>Features:</strong> Marfanoid habitus, lens dislocation, thromboembolic events, intellectual disability.</li>
      <li><strong>Treatment:</strong> Vitamin B6 (pyridoxine), low-methionine diet, betaine, folic acid, B12.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">2. Phenylketonuria (PKU)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Case+1+Overview+2024.pdf</li>
      <li><strong>Type:</strong> Autosomal recessive disorder.</li>
      <li><strong>Defect:</strong> Phenylalanine hydroxylase deficiency → phenylalanine accumulation.</li>
      <li><strong>Symptoms:</strong> Intellectual disability, microcephaly, fair complexion, musty odor.</li>
      <li><strong>Management:</strong> Low phenylalanine diet, newborn screening critical.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">3. Barrett’s Oesophagus</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Neoplastic+%26+Non+Neoplastic+Growth+Disorders+23s.pdf</li>
      <li><strong>Definition:</strong> Metaplasia of lower oesophageal squamous epithelium to columnar epithelium.</li>
      <li><strong>Cause:</strong> Gastro-oesophageal reflux disease (GORD).</li>
      <li><strong>Risk:</strong> Progression to oesophageal adenocarcinoma.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">4. Alzheimer’s Disease</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Neoplastic+%26+Non+Neoplastic+Growth+Disorders+23s.pdf</li>
      <li><strong>Change:</strong> Cerebral atrophy.</li>
      <li><strong>Histology:</strong> Narrowed gyri, widened sulci.</li>
      <li><strong>Mechanism:</strong> Atrophy from neuronal loss and apoptosis.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">5. Tuberculosis (TB)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Necrosis Type:</strong> Caseous necrosis.</li>
      <li><strong>Histology:</strong> Amorphous pink material, granulomatous inflammation.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">6. Acute Pancreatitis</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Mechanism:</strong> Fat necrosis due to enzymatic digestion of fat.</li>
      <li><strong>Cause:</strong> Alcohol or gallstones.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">7. Vasculitis</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Feature:</strong> Fibrinoid necrosis in vessel walls.</li>
      <li><strong>Example:</strong> Seen in autoimmune vasculitis and immune complex deposition.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">8. Myocardial Infarction (MI)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Necrosis Type:</strong> Coagulative necrosis.</li>
      <li><strong>Microscopy:</strong> Loss of nuclei, eosinophilic cytoplasm, acute inflammation.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">9. Stroke (Cerebral Infarct)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Necrosis Type:</strong> Liquefactive necrosis.</li>
      <li><strong>Unique:</strong> Brain lacks structural support → liquefaction into cysts.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">10. Follicular Lymphoma</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Feature:</strong> Overexpression of Bcl-2 → inhibition of apoptosis.</li>
      <li><strong>Pathology:</strong> Enhanced survival of abnormal lymphocytes.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">11. Systemic Lupus Erythematosus (SLE)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Mechanism:</strong> Defective apoptosis clearance → nuclear antigens → autoimmunity.</li>
      <li><strong>Result:</strong> Production of autoantibodies.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">12. Type 1 Diabetes Mellitus</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Mechanism:</strong> Autoimmune-mediated apoptosis of pancreatic β-cells.</li>
      <li><strong>Result:</strong> Insulin deficiency.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">13. HIV</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> Cell+Death+24sh.pdf</li>
      <li><strong>Mechanism:</strong> Induces apoptosis in both infected and uninfected CD4+ T-cells.</li>
      <li><strong>Result:</strong> Progressive immune suppression.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">14. Autism Spectrum Disorder (Association)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> MED1028-Microbiome.pdf</li>
      <li><strong>Link:</strong> Dysbiosis in GF mice → altered sociability and repetitive behavior.</li>
      <li><strong>Relevance:</strong> Studied via gut-brain axis.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">15. Clostridium difficile Infection (CDI)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Lecture:</strong> MED1028-Microbiome.pdf</li>
      <li><strong>Link:</strong> Result of antibiotic-induced dysbiosis.</li>
      <li><strong>Symptoms:</strong> Diarrhoea, inflammation, and pseudomembranous colitis.</li>
    </ul>
  </div>
</div>
<div class="summary-item">
  <button class="summary-toggle">16. MCADD (Medium-Chain Acyl-CoA Dehydrogenase Deficiency)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Genetics:</strong> Autosomal recessive; mutation in the <code>ACADM</code> gene.</li>
      <li><strong>Mechanism:</strong> Impaired fatty acid oxidation during fasting or stress → energy failure.</li>
      <li><strong>Presentation:</strong> Often in infancy (1–24 months); hypoglycaemia, seizures, lethargy, coma, sudden death.</li>
      <li><strong>Diagnosis:</strong> Newborn screening (blood spot).</li>
      <li><strong>Treatment:</strong> Avoid fasting, emergency glucose during illness, carnitine supplementation (sometimes).</li>
    </ul>
  </div>
</div>
<div class="summary-item">
  <button class="summary-toggle">17. DRESS Syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms)</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cause:</strong> Severe hypersensitivity reaction to certain medications (e.g. allopurinol, anticonvulsants).</li>
      <li><strong>Presentation:</strong> Rash, fever, lymphadenopathy, eosinophilia, liver/kidney involvement.</li>
      <li><strong>Histopathology:</strong> Eosinophil-rich inflammation and necrotic keratinocytes.</li>
      <li><strong>Treatment:</strong> Stop offending drug, corticosteroids, supportive care.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">18. Cellulitis</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cause:</strong> Infection of dermis and subcutaneous tissue, often due to Streptococcus pyogenes or Staphylococcus aureus.</li>
      <li><strong>Histology:</strong> Neutrophilic infiltration through epidermis, dermis, and subcutaneous fat.</li>
      <li><strong>Clinical:</strong> Rapid onset redness, warmth, swelling, pain. May follow skin trauma (e.g. cat scratch).</li>
      <li><strong>Treatment:</strong> Empirical antibiotics (e.g. flucloxacillin).</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">19. Impetigo</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cause:</strong> Superficial skin infection, typically caused by Staphylococcus aureus or Streptococcus pyogenes.</li>
      <li><strong>Clinical:</strong> Golden, crusted lesions, usually around nose and mouth in children.</li>
      <li><strong>Histology:</strong> Intraepidermal vesicles with neutrophils and bacteria.</li>
      <li><strong>Treatment:</strong> Topical or oral antibiotics (e.g. fusidic acid or flucloxacillin).</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">20. Tattoo-Related Granulomatous Reaction</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cause:</strong> Foreign body reaction to tattoo pigment.</li>
      <li><strong>Histology:</strong> Non-caseating granulomas in skin containing pigment.</li>
      <li><strong>Clinical:</strong> Papular or nodular overgrowths developing over tattooed skin weeks after procedure.</li>
      <li><strong>Differential:</strong> Must exclude sarcoidosis or cutaneous TB.</li>
    </ul>
  </div>
</div>

<div class="summary-item">
  <button class="summary-toggle">21. Diabetic Foot Ulcer</button>
  <div class="summary-content">
    <ul>
      <li><strong>Cause:</strong> Peripheral neuropathy and vascular insufficiency in diabetes.</li>
      <li><strong>Clinical:</strong> Chronic foot ulcers, usually painless, often infected.</li>
      <li><strong>Histology:</strong> Ulceration with granulation tissue and possible secondary infection.</li>
      <li><strong>Treatment:</strong> Glycaemic control, offloading pressure, wound care, antibiotics.</li>
    </ul>
  </div>
</div>
    <!-- Add more condition blocks here -->
  </div>
</section>
  <script>
const questions = [];

  </script>
	
  <script src="msk-data1.js"></script>
	
  <script src="msk-data2.js"></script>

  <script src="script.js"></script>

</body>
</html>
